Comparison Soleno Therapeutics (SLNO) with Competitors
Soleno Therapeutics (SLNO) industry is Biotechnology.
Profit Margin
SLNO33.17%
Industry-0.77%
Upside+33.94%
Operating Margin
SLNO33.06%
Industry-2055.25%
Upside+2088.31%
Debt-to-Equity
SLNO10.06%
Industry28.27%
Upside-64.42%
Free Cash Flow Yield
SLNO3.85%
Industry-1.75%
Upside+5.59%
P/E
SLNO29.02
Industry-20.52
Upside+4953.24%
Forward P/E
SLNO13.12
Industry16.33
Upside-19.66%